James M. Murphy 个人学术档案

引用次数

	总计	2019 年至今
引用	13751	9697
h 指数	64	56
i10 指数	145	125

2100

1050

525

1575

2008200920102011201220132014201520162017201820192020202120222023202456 55 82 72 93 146 390 510 666 806 1029 1225 1496 1885 2028 1974 1077

开放获取的出版物数量

查看全部

134 篇文章

30 篇文章

可查看的文章

无法查看的文章

根据资助方的强制性开放获取政策

合著作者

John SilkeProfessor, The Walter and Eliza Hall Institute在 latrobe.edu.au 的电子邮件经过验证
Joanne (Hulett) HildebrandSenior Research Scientist, WEHI在 wehi.edu.au 的电子邮件经过验证
jeff babonwalter and eliza hall institute在 wehi.edu.au 的电子邮件经过验证
Andrew I. WebbAssociate Professor - The Walter and Eliza Hall Institute在 wehi.edu.au 的电子邮件经过验证
James E VinceThe Walter and Eliza Hall Institute of Medical Research在 wehi.edu.au 的电子邮件经过验证
Renwick CJ DobsonProfessor of Chemical Biology, School of Biological Sciences, University of Canterbury在 canterbury.ac.nz 的电子邮件经过验证
Jarrod SandowThe Walter and Eliza Hall Institute在 wehi.edu.au 的电子邮件经过验证
Maria C TanzerMax-Planck of Biochemistry在 biochem.mpg.de 的电子邮件经过验证
Blewitt ME, Blewitt M, Champ MELaboratory head, Walter and Eliza Hall Institute在 wehi.edu.au 的电子邮件经过验证
Kate E LawlorGroup Head, Cell Death and Inflammatory Signalling, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research and Adjunct Research Fellow, Department of Molecular and Translational Science, Monash University在 hudson.org.au 的电子邮件经过验证
Patrick A. EyersHead of Biochemistry, Cell & Systems Biology, University of Liverpool. CSO Sulantrix Ltd在 liverpool.ac.uk 的电子邮件经过验证
Lachlan WhiteheadWalter and Eliza Hall Institute of Medical Research在 wehi.edu.au 的电子邮件经过验证
Peter D MaceProfessor, University of Otago, New Zealand在 otago.ac.nz 的电子邮件经过验证
Andreas StrasserThe Walter and Eliza Hall Institute在 wehi.edu.au 的电子邮件经过验证
Jaclyn S PearsonPhD Hudson Institute of Medical Research在 hudson.org.au 的电子邮件经过验证
Kelly Lee ROGERSHead, Centre for Dynamic Imaging, Walter and Eliza Hall Institute在 wehi.edu.au 的电子邮件经过验证
frank sicheriLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital在 lunenfeld.ca 的电子邮件经过验证
Wai-Hong ThamWalter and Eliza Hall Institute在 wehi.edu.au 的电子邮件经过验证
Gerard ManningDirector of Bioinformatics, Genentech在 gene.com 的电子邮件经过验证

关注

James M. Murphy

Head of Inflammation Division, Walter and Eliza Hall Institute of Medical Research

在 wehi.edu.au 的电子邮件经过验证 - 首页

kinases pseudokinases cell death necroptosis signal transduction


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism JM Murphy, PE Czabotar, JM Hildebrand, IS Lucet, JG Zhang, ... Immunity 39 (3), 443-453, 2013	1168	2013
RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis JA Rickard, JA O’Donnell, JM Evans, N Lalaoui, AR Poh, TW Rogers, ... Cell 157 (5), 1175-1188, 2014	594	2014
Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death JM Hildebrand, MC Tanzer, IS Lucet, SN Young, SK Spall, P Sharma, ... Proceedings of the National Academy of Sciences 111 (42), 15072-15077, 2014	570	2014
Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner SA Conos, KW Chen, D De Nardo, H Hara, L Whitehead, G Núñez, ... Proceedings of the National Academy of Sciences 114 (6), E961-E969, 2017	403	2017
The molecular basis of JAK/STAT inhibition by SOCS1 NPD Liau, A Laktyushin, IS Lucet, JM Murphy, S Yao, E Whitlock, ... Nature communications 9 (1), 1558, 2018	377	2018
The molecular regulation of Janus kinase (JAK) activation JJ Babon, IS Lucet, JM Murphy, NA Nicola, LN Varghese Biochemical Journal 462 (1), 1-13, 2014	377	2014
Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity JJ Babon, NJ Kershaw, JM Murphy, LN Varghese, A Laktyushin, ... Immunity 36 (2), 239-250, 2012	319	2012
SOCS3 binds specific receptor–JAK complexes to control cytokine signaling by direct kinase inhibition NJ Kershaw, JM Murphy, NPD Liau, LN Varghese, A Laktyushin, ... Nature structural & molecular biology 20 (4), 469-476, 2013	314	2013
Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure T Müller, C Dewitz, J Schmitz, AS Schröder, JH Bräsen, BR Stockwell, ... Cellular and Molecular Life Sciences 74, 3631-3645, 2017	303	2017
MK2 phosphorylates RIPK1 to prevent TNF-induced cell death I Jaco, A Annibaldi, N Lalaoui, R Wilson, T Tenev, L Laurien, C Kim, ... Molecular cell 66 (5), 698-710. e5, 2017	278	2017
A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties JM Murphy, Q Zhang, SN Young, ML Reese, FP Bailey, PA Eyers, ... Biochemical Journal 457 (2), 323-334, 2014	278	2014
TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice JA Rickard, H Anderton, N Etemadi, U Nachbur, M Darding, N Peltzer, ... Elife 3, e03464, 2014	256	2014
Regulated necrosis in kidney ischemia-reperfusion injury A Pefanis, FL Ierino, JM Murphy, PJ Cowan Kidney international 96 (2), 291-301, 2019	244	2019
MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis AL Samson, Y Zhang, ND Geoghegan, XJ Gavin, KA Davies, ... Nature communications 11 (1), 3151, 2020	232	2020
Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax J Gruszczyk, U Kanjee, LJ Chan, S Menant, B Malleret, NTY Lim, ... Science 359 (6371), 48-55, 2018	201	2018
Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis EJ Petrie, JJ Sandow, AV Jacobsen, BJ Smith, MDW Griffin, IS Lucet, ... Nature communications 9 (1), 2422, 2018	180	2018
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation JS Pearson, C Giogha, S Mühlen, U Nachbur, CLL Pham, Y Zhang, ... Nature microbiology 2 (4), 1-10, 2017	179	2017
TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1 DM Moujalled, WD Cook, T Okamoto, J Murphy, KE Lawlor, JE Vince, ... Cell death & disease 4 (1), e465-e465, 2013	178	2013
cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1-and RIPK3-dependent manner WWL Wong, JE Vince, N Lalaoui, KE Lawlor, D Chau, A Bankovacki, ... Blood, The Journal of the American Society of Hematology 123 (16), 2562-2572, 2014	175	2014
HSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death AV Jacobsen, KN Lowes, MC Tanzer, IS Lucet, JM Hildebrand, EJ Petrie, ... Cell death & disease 7 (1), e2051-e2051, 2016	158	2016

系统目前无法执行此操作，请稍后再试。

文章 1–20

每年引用数

重复的引用

合并的引用

添加合著者合著作者

上传 PDF

关注此作者

引用次数

合著作者

引用